DRUG · Unmapped registry intervention
Iguratimod
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
NCT02275299
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Leflunomide
Normalized identity: leflunomideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Methotrexate
Normalized identity: methotrexateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
IguratimodDRUG
LeflunomideDRUG · verified · RxNorm: leflunomide
MethotrexateDRUG · verified · RxNorm: methotrexate
Sponsors & collaborators
Jiangsu Simcere Pharmaceutical Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02275299 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.